IPHYF
Price
$1.31
Change
-$0.64 (-32.82%)
Updated
Jul 7 closing price
Capitalization
183.92M
KNBIF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jul 23 closing price
Capitalization
4.87M
Interact to see
Advertisement

IPHYF vs KNBIF

Header iconIPHYF vs KNBIF Comparison
Open Charts IPHYF vs KNBIFBanner chart's image
Innate Pharma
Price$1.31
Change-$0.64 (-32.82%)
Volume$450
Capitalization183.92M
Kane Biotech
Price$0.03
Change-$0.00 (-0.00%)
Volume$10.8K
Capitalization4.87M
IPHYF vs KNBIF Comparison Chart in %
Loading...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHYF vs. KNBIF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHYF is a Hold and KNBIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (IPHYF: $1.31 vs. KNBIF: $0.03)
Brand notoriety: IPHYF and KNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHYF: 42% vs. KNBIF: 35%
Market capitalization -- IPHYF: $183.92M vs. KNBIF: $4.87M
IPHYF [@Biotechnology] is valued at $183.92M. KNBIF’s [@Biotechnology] market capitalization is $4.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHYF’s FA Score shows that 0 FA rating(s) are green whileKNBIF’s FA Score has 1 green FA rating(s).

  • IPHYF’s FA Score: 0 green, 5 red.
  • KNBIF’s FA Score: 1 green, 4 red.
According to our system of comparison, KNBIF is a better buy in the long-term than IPHYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHYF’s TA Score shows that 4 TA indicator(s) are bullish while KNBIF’s TA Score has 2 bullish TA indicator(s).

  • IPHYF’s TA Score: 4 bullish, 3 bearish.
  • KNBIF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, IPHYF is a better buy in the short-term than KNBIF.

Price Growth

IPHYF (@Biotechnology) experienced а 0.00% price change this week, while KNBIF (@Biotechnology) price change was -12.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.76%. For the same industry, the average monthly price growth was +19.76%, and the average quarterly price growth was +29.65%.

Reported Earning Dates

IPHYF is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+8.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHYF($184M) has a higher market cap than KNBIF($4.87M). IPHYF YTD gains are higher at: -54.828 vs. KNBIF (-62.338).
IPHYFKNBIFIPHYF / KNBIF
Capitalization184M4.87M3,775%
EBITDAN/A-3.7M-
Gain YTD-54.828-62.33888%
P/E RatioN/A1.07-
RevenueN/A2.44M-
Total CashN/A494K-
Total DebtN/A2.08M-
FUNDAMENTALS RATINGS
IPHYF vs KNBIF: Fundamental Ratings
IPHYF
KNBIF
OUTLOOK RATING
1..100
9685
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
9296
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KNBIF's Valuation (32) in the null industry is somewhat better than the same rating for IPHYF (70). This means that KNBIF’s stock grew somewhat faster than IPHYF’s over the last 12 months.

KNBIF's Profit vs Risk Rating (100) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

IPHYF's SMR Rating (93) in the null industry is in the same range as KNBIF (100). This means that IPHYF’s stock grew similarly to KNBIF’s over the last 12 months.

IPHYF's Price Growth Rating (92) in the null industry is in the same range as KNBIF (96). This means that IPHYF’s stock grew similarly to KNBIF’s over the last 12 months.

KNBIF's P/E Growth Rating (93) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPHYFKNBIF
RSI
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
44%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRN1.150.03
+2.68%
Barnwell Industries
IDT57.410.34
+0.60%
IDT Corp
RUSHB54.42-0.32
-0.58%
Rush Enterprises
LYG4.24-0.05
-1.17%
Lloyds Banking Group PLC
BTMD4.16-0.08
-1.89%
Biote Corp

IPHYF and

Correlation & Price change

A.I.dvisor tells us that IPHYF and KNBIF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHYF and KNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
KNBIF - IPHYF
6%
Poorly correlated
N/A
INNMF - IPHYF
6%
Poorly correlated
-10.00%
OTLC - IPHYF
4%
Poorly correlated
-0.49%
ISCO - IPHYF
1%
Poorly correlated
-16.06%
LIXT - IPHYF
1%
Poorly correlated
+3.37%
More

KNBIF and

Correlation & Price change

A.I.dvisor tells us that KNBIF and CADL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNBIF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNBIF
1D Price
Change %
KNBIF100%
N/A
CADL - KNBIF
22%
Poorly correlated
+0.57%
LQDA - KNBIF
21%
Poorly correlated
+5.75%
SPHDF - KNBIF
20%
Poorly correlated
N/A
MMIRF - KNBIF
12%
Poorly correlated
N/A
IPHYF - KNBIF
6%
Poorly correlated
N/A
More